Background and Objective: The c-secretase inhibitor (GSI) has been shown to inhibit expression of amyloid beta (Ab), but GSI also has a side effect of reducing cell survival. Since low-power laser irradiation (LLI) has been known to promote cell survival, we examined whether 532 nm LLI can rescue the GSI side effect or not.
Introduction
Alzheimer's disease is a serious problem for aged individuals. The number of patients will almost double every 20 years, reaching 65.7 million in 2030 and 115.4 million in 2050 [1] . Amyloid beta (Ab) is considered as a pathogenic agent of Alzheimer's disease that is processed from amyloid precursor protein (APP) by c-secretase (GS) [2] . Intracellular as well as extracellular accumulations of Ab result in nerve cell toxicity [3] . As GS activity is essential for the release of intact Ab, c-secretase inhibitors (GSIs) have been contemplated for the treatment of Alzheimer's disease. Since GSIs have been shown to decrease Ab production after administration to transgenic mice overexpressing human APP [4] , they were considered as useful drugs to lower Ab accumulation for long-term treatment in human patients [5, 6] .
Despite of the potential benefit, GSIs could have heavy side effects. It is well known that GS-mediated intracellular processes activate Notch signaling pathway, which is associated with cell proliferation and differentiation [7] [8] [9] . Notch regulates the expression of a phosphatase PTEN (Phosphatase and Tensin homolog deleted from chromosome) via intracellular Notch (ICN), the intracellular moiety of Notch. ICN, when released from Notch by GS, suppresses the expression of PTEN, which dephosphorylates a phosphoinositides that is critical for activation of Akt, a Ser/Thr kinase [10] . Activated Akt plays key roles in mediating cell proliferation, cell survival (anti-apoptotic), cell-cycle progression, differentiation, transcription, translation, and glucose metabolism [11, 12] . Therefore, although GSIs could be effective for treating Alzheimer's disease with their inhibitory role of Ab expression and accumulation, they have unwanted side effects of suppressing cell proliferation and survival by inhibiting Akt activation via PTEN elevation. These dual aspects of GSIs await other novel drugs or treatments that ameliorate the side effects.
It has been reported that the low-power laser irradiation (LLI) can promote cell proliferation and survival. Mester et al. first reported such effects on intractable skin ulcer in 1968 [13] . Since then, there are many studies showing LLI-mediated cell proliferation and survival in various fields including wound healing, reumatoid arthritis, tendinopathy, osteoarthritis [14] [15] [16] [17] [18] . In studies using cell culture systems, it was demonstrated that 532 nm LLI promoted proliferation of B-14 (Chinese hamster ovarian cell line) cells without inducing cell death [19] . Another study showed the 532 nm LLI on blood platelets can trigger signal transduction, leading to platelet activation, as well as the gradual loss of natural platelet reactivity and platelets' ability to respond to activating agents [20] . Mechanisms of these cell proliferating effects of 532 nm LLI are unclear, but recent work using 632.8 nm LLI indicated that Akt activation is involved in prevention of cell apoptosis [21] .
Here we examined the effects of 532 nm LLI on cell proliferation in human-derived glioblastoma (A-172) and aimed to reveal mechanisms underlying LLI effects by investigating the involvement of the Notch-Akt signaling pathway.
Materials and Methods
We performed all experiments in accordance with the Declaration of Helsinki and Guide for Animal Experimentation at Soka University.
Laser Irradiation Method
A diode laser apparatus (Nd:YVO 4 , CW, 532 nm, 0-180 mW) was used. The experiment was conducted in a clean bench under 37uC and 5% CO 2 . The laser beam was reflected on a mirror and introduced to cells from the top to the bottom. The averaged power was 60 mW and the irradiated area was 7.1 mm 
Cell Culture of Glioblastoma (A-172)
The human-derived glioblastoma A-172 cell line was obtained from JCRB (#0228). The cells were cultured in 25 cm 2 flasks with DMEM containing 10% fetal bovine serum and incubated in an atmosphere of 5% CO 2 , 95% air at 37uC. The medium was changed once every three days to maintain cell growth. Trypsinization was performed using 0.1% trypsin-PBS once the cells reached confluency (10 6 cells). Cells were plated in 35 mm dish, 96-well plates (MS-8096F, Sumitomo Bakelite Co. Ltd., Tokyo, Japan), or LAB-TEK Chamber Slide (Nalge Nunc International, New York, USA) with 10% FBS-DMEM medium at 6610 3 cells/ml.
Cell Counting by Microscopic Observations
On the day following plating, culture wells on the clean bench maintained at 37uC and in an atmosphere containing 5% CO 2 were photographed with a digital camera before LLI. After taking photographs, the plate was returned to the incubator. Photos were taken immediately after LLI, and 24 and 48 h after LLI. The photos were displayed on a PC monitor and cells were counted per unit area in all areas including the directly irradiated area.
Cell Viability by MTT Assay
Cell viability was measured by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) colorimetric assay. The A-172 cells were plated at 0.3 6 10 4 cells/well in a 96-well plate (200 ml/well) and incubated for 12 hours. At 48 h after LLI, the culture medium was removed, and 200 ml of fresh medium containing 20 ml of MTT (6 mg/ml; Sigma-Aldrich Japan, Tokyo, Japan) was added to each well. The cells were incubated at 37uC for 3 h. Colored precipitates were extracted with 100 ml of acidic isopropanol at room temperature for 1 h, and the absorbance was measured at 570 nm using a plate reader.
Immunofluorescent Staining Method
The cells were rinsed three times with PBS after LLI. They were fixed with 4% PFA, treated with 0.1% Triton X-100 and blocked by 1% BSA-PBS. Primary antibody against phospho-Thr308-Akt (1:800, Cell Signaling), phospo-Ser473-Akt (1:800, Promega), phosphor-Ser380/Thr382/383-PTEN (1:100, Cell Signaling), or Ab-Amyloid (1:50, Cell Signaling) was added and left overnight at 4uC. Next day, secondary antibody (Rhodamine, FITC) was added and left for 3 h under room temperature. After washing with PBS, glycerol was added and cover glass was put on. Stained cells were observed by a fluorescent microscope (BZ-9000, KEYENCE, Tokyo, Japan). The center of each well was photographed with same exposure time using a 20x objective lens after focusing on cells under phase contrast. The maximum intensity in irradiated area was measured using an optional software (BZ-analysis application, KEYENCE) without applying any image enhancement. However, the haze reduction was used to make fluorescent images clearer.
Pretreatment Cells with c-secretase Inhibitor (GSI)
DAPT, a typical agent of GSIs, was cryopreserved at 1 mM in DMSO. DAPT was added directly to FBS-DMEM medium at 25 mM and applied to cells 3 h before LLI. DMSO (1% in the medium) showed harmless effects in preliminary experiments (data not shown).
Analysis of ATP Level in Cell Lysate
An ATP/ADP ratio assay kit (EnzyLightTM, BioAssay Systems, CA, USA) was used to quantify ATP amount. A-172 cells were plated at 0.5610 4 cells/well in a 96-well plate (200 ml/well) and incubated for 12 hours. The culture medium was removed after LLI. 90 ml ATP reagent was added to each 96-well and mixed by tapping the plate. After 1 min, luminescence (RLU A) was read on a luminometer (ATTO BIO-INSTRUMENT, Tokyo, Japan). 10 minutes after measuring RLU A, the luminescence of samples was read again (RLU B). This measurement provides the background prior to measuring ADP. Immediately following RLU B measurement, 5 ml ADP reagent was added to each well and mixed by pipetting up and down. After 1 min, luminescence (RLU C) was read for ADP level. The following formula was used to calculate ATP/ADP ratio: (RLU C -RLU B)/RLU A.
Statistical Analysis
All values were presented as mean 6 SD. Student's two-tailed non-paired t-test and one-way ANOVA were used to analyze statistical differences between 2 groups or among multiple groups, respectively.
Results

Effects of 532 nm LLI on the Number of A-172 Cells
We have examined if LLI affects the proliferation of A-172 cells grown in culture. The cells were plated at 0.3 6 10 4 cells/well in 96-well plates and were irradiated with 532 nm LLI for 0 (no LLI: control), 20, 40, and 60 min. The number of cells remaining at 24 and 48 hours after LLI was counted and compared to that before LLI (Pre-LLI) (Fig. 1) . At 24 h after LLI, the proliferation ratio, the number of remaining cells after LLI normalized to that of untreated control, was 110614%, 111616%, or 111617% for 20 min, 40 min, or 60 min LLI, respectively (Fig. 1B-left bars, no significances among any groups). At 48 h, they were 158615% for control, 170619%, 175618%, or 180612% for 20 min, 40 min, and 60 min LLI, respectively (Fig. 1B , right bars, n = 12, p,0.05 for 20 and 40 min LLI, p,0.01 for 60 min LLI).
In addition to cell counts, we also used a calorimetric method to quantify the proliferation and survival in cell culture using the MTT assay. The mean optical density at 570 nm at 48 hours after 40 or 60 min LLI increased significantly over non-irradiated control (Fig. 1C, n = 16 , p,0.01 for 40 and 60 min LLI), while little change was observed with 20 min LLI.
Expressions of p-Akt and p-PTEN by 532 nm LLI
To examine possible involvement of Akt signaling in the LLImediated proliferation, we investigated Akt as well as PTEN activation (Fig. 2) . Anti-phosphorylated Akt (p-Akt) antibodies detect activated (phosphorylated) Akt molecules, while antiphosphorylated PTEN (p-PTEN) antibodies detect PTENs that removed the phosphate group from activated phosphoinositides and retained it [22] . With 20 min LLI, the intensity of p-PTEN immunofluorescence did not change significantly (9562% of control). However, with 40 and 60 min LLI, the p-PTEN immunofluorescence intensity decreased significantly over control (8865%, p,0.05, for 40 min; 8763%, p,0.05, for 60 min) (n = 120:4 experiments and 30 selected cells each). In contrast, pAkt immunofluorescence intensity significantly increased (12264%, 12961%, and 18568% for 20, 40, and 60 min LLI over control, p,0.05 or p,0.01).
Effects of a Combined Application of GSI and LLI on Cell Proliferation
DAPT, a typical agent of GSIs, has been previously shown to retard cell proliferation by reducing generation of ICN [23] . We also tested this agent in A-172 cells in 13 experiments. At 24 h after LLI, the standardized proliferation ratios were 178616% for control group, 196626% for experimental group which received 60 min LLI only, 14469% for pretreated group with GSI, and 18668% for group received both applications, respectively. At 48 h after LLI, they were 282627, 302637, 16864, and 216616%, respectively (Fig. 3 ). There were statistical significances between some pairs of groups as shown in Fig. 3 Effects of LLI on Intracellular Signaling Molecules under GSI Fig. 4A describes the action of GS in relation to Notch and APP processing. GS cleaves Notch as well as APP at plasma membrane, making ICN and Ab, respectively. When GS is inhibited by GSI, ICN level will be reduced and PTEN expression will increase, resulting in suppression of Akt signaling pathway and in inhibition of cell proliferation and survival (Fig.4B) . Similarly, Ab level will decrease as more uncleaved APP will remain.
We next tested if the LLI-mediated rescue of GSI-induced reduction in cell number (Fig. 3) involves activation of Akt and the reduction of PTEN. As described above, A-172 cells were treated with DAPT for 3 hours, exposed to LLI for 20, 40, and 60 min, and fixed at 15 min for the immunofluorescent staining of p-Akt and p-PTEN (Fig. 4C) . Immunofluorescence intensity was quantified for each protein and normalized to non-DAPT treated control (Fig. 4D ) (n = 120:4 experiments and 30 selected cells each). As expected, DAPT treatment increased the expression of p-PTEN (11463% when standardizing untreated control as 100%, p,0.01), suggesting that PTEN expression has increased due to inhibition of GS and reduction of ICN. We also examined if soluble Ab is reduced by immunofluorescent staining using antiAb antibodies. As would be expected for the inhibition of GS, Ab was reduced in DAPT-treated cells (8261%, p,0.01). We then tested if LLI could alter the expression of p-PTEN as well as Ab. Simultaneous application of 20 min LLI reduced p-PTEN to the control level, but did not affect already reduced Ab level. Effects of 40 and 60 min LLI were similar to 20 min LLI. These data suggest that LLI, within 20 min, acts specifically on the Notch pathway to reduce PTEN expression, but does little to the APP processing and homeostasis of Ab.
Immunofluorescence intensity of p-Akt was reduced slightly from the control level in DAPT-treated cells (9461%, p,0.01). This decrease was rescued by LLI. With 20 min LLI, the immnofluorescent staining of p-Akt was recovered to the control level. With 40 and 60 min LLI, the intensity significantly increased 112621% (p,0.01) and 137636% (p,0.01) above the control level, respectively. These data suggest that LLI could recover DAPT-induced reduction of p-Akt in a dose-dependent manner.
Effects of LLI on ATP Level in Cell Lysates
To test the possibility that LLI-induced cell proliferation involves ATP elevation, we examined ATP level in cell lysates using ATP/ADP ratio assay kit (Fig. 5) . Mean luminescence after 
Discussion
In the present study, using conventional cell counting and the colorimetric MTT assay, we demonstrate that 532 nm LLI (60 mW) significantly increased viability of human-derived glioblastoma A-172 cells. The effect showed a LLI dose-dependency with 60 min LLI being the most effective for cell proliferation. These findings contrast to studies using LLI of other wavelengths in the same cell type. The infra-red 808 nm LLI delayed cell cycle and suppressed cell proliferation [24] , and the 405 nm LLI promoted the cell death in A-172 cells [25] . Thus, the effect of LLI on the cell proliferation appears to depend on the wavelength. Indeed, LLI wavelength-dependent effects were previously reported in various cell types [26] .
Different effects of LLI wavelength on cell proliferation and survival may depend on photoacceptors present in mitochondria, especially those in the mitochondrial respiratory chain [27] . Primary photoacceptors include cytochromes c oxidase (red and near-infrared light region), NADH-dehydrogenase (blue spectral region), and cytochromes b, c1 and c (green light region). Their cofactors are porphyrins (for cytochrome c oxidase and cytochromes b, c1 and c), or flavins (for NADH-dehydrogenase), respectively [28] . These photoreceptors and cofactors contribute to the generation of ATP, a critical source of chemical energy in cells. Mitochondria are the center of many diverse cellular functions such as signaling, cellular differentiation, cell death, as well as the control of the cell cycle and cell growth [29] . Thus photoacceptors in mitochondria upon light absorption may regulate the level of ATP to support cell survival. However, considering that LLI has different biological effects on different cells, it is difficult to conceive that the regulation of mitochondrial photoacceptors is the only mechanism underlying LLI-mediated cell proliferation. It is likely that final consequences of specific photobiological effects are determined not at the level of primary reactions in the mitochondrial respiratory chain but based on secondary cellular signaling [27] . It will be important to characterize how proteins and enzymes expressed in each cell type contribute to photobiological effects.
The present study focused on the effect of LLI on the Notch-PTEN-Akt pathway in glioblastoma. We showed a reciprocal expression of p-PTEN inactivation and p-Akt activation in Fig. 2 . Previous work of others showed the effects of LLI on the mitogenactivated protein kinase (MAPK) pathway [30] and the ROS-Src pathway [31] . To our knowledge, this is the first to report that LLI at any wavelength influenced the Notch pathway. Previously, it was suggested that Akt plays a key role for cell survival and proliferation [32] . Using FRET, it was demonstrated that 632 nm LLI increased cell proliferation via the activation of Akt signaling pathway [33] . It was also reported that 632.8 nm LLI inhibits the expression of p21 [34] , a molecule that arrests the cell-cycle, and enhances the cell-cycle progress via its phosphorylation by Akt [35] . Recent investigations implicate an important role of Akt in mitochondria for the regulation of cell growth. The expression level of Akt in mitochondria is dynamically regulated by cellular signaling activities [36] , and Akt mediates mitochondrial protection in cardiomyocytes [37] . Importantly, Akt suppresses apoptosis signaling independent of cytosolic Akt in cardiac muscle cells [38] . Considering a number of studies addressing the effects of LLI on mitochondria [39] , our study may have revealed Akt as an interesting link between LLI and mitochondria.
GSI has been proposed for the treatment of Alzheimer's disease because its inhibition of GS will decrease the generation of intracellular Ab, a potential culprit in Alzheimer's disease [40] . However, GSI treatment will also cause a side effect in healthy cells in Alzheimer's disease patients since GSI will prevent the normal processing of Notch, whose cleavage by GS at plasma membrane generates ICN, a PTEN suppressor and an Akt enhancer, promoting cell survival [41, 42] . In this study, we observed that GSI down-regulated Ab and upregulated PTEN, suppressing Akt activation and depressing cell proliferation and cell survival as predicted from previous studies. We also showed that 532 nm LLI was able to decrease PTEN expression of GSIpretreated cells and to increase Akt expression of those cells while keeping Ab suppressed. We further demonstrated that the LLI rescued the depression of cell proliferation and even induced further growth. Thus, LLI may be useful to prevent the side effect in the Alzheimer's disease treatment using GSI. Future studies will examine the combined administration of GSI and 532 nm LLI in animal models of Alzheimer's disease in vivo. 
